Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
63.8M
-
Shares change
-
-809K
-
Total reported value, excl. options
-
$2.77B
-
Value change
-
-$17.9M
-
Put/Call ratio
-
1.22
-
Number of buys
-
86
-
Number of sells
-
-109
-
Price
-
$43.33
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2020
252 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2020.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.8M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.88M shares), VANGUARD GROUP INC (5.63M shares), BlackRock Inc. (4.49M shares), FMR LLC (4.34M shares), Bellevue Group AG (4.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.97M shares), STATE STREET CORP (2.62M shares), Rock Springs Capital Management LP (2.52M shares), Casdin Capital, LLC (2.38M shares), and ORBIMED ADVISORS LLC (2.21M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.